Skip to content

Immunological and Pathological Evaluation of Chronic Fungal Infections of Skin

Immunohistochemical Evaluation of Chronic and Recurrent Dermatophytosis - I.C.A.R.D.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/030925
Enrollment
48
Registered
2021-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Skin Biopsy: 1.Cases - Two samples per patient, one from the border of the active lesion and the other from normal looking surrounding skin, will be taken with a standard dermatological

Sponsors

Dr Ramesh Bhat M
Lead Sponsor
Dr Jyothi J
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: (i)CASES - aged 18 years and above with chronic(defined as â??patients who have suffered from the disease for at least 6 months duration, in spite of being treated.â??) and recurrent dermatophytosis (defined as â??occurrence of the dermatophyte infection within few weeks , after completion of treatmentâ??) Patients willing to give informed consent. ii)CONTROLS- aged 18 years and above, who have been successfully treated for dermatophytosis and newly diagnosed cases of dermatophytosis , after obtaining informed consent. The non-lesional (normal looking) skin will be selected for biopsy. iii)Patients willing to give informed consent

Exclusion criteria

Exclusion criteria: (i)Patients aged below 18 years (ii)Patients who are pregnant (iii)Patients with superficial dermatophytosis of less than 6 months duration. (iii) patients without any comorbidity affecting the immune response or predisposing to dermatophytosis (e.g., primary or secondary immunosuppression, diabetes mellitus, Cushingâ??s disease, transplant recipients) iv)Patients unwilling to give consent

Design outcomes

Primary

MeasureTime frame
Immune cell populations ( cases and controls) through the following immunohistochemical markers will be counted : 1. CD1 a+ - Langerhan Cells 2. CD 68 + - Macrophages 3. Factor XIII a + - Dermal dendrocytes Timepoint: At the time of skin biopsy

Secondary

MeasureTime frame
Comparison of immune cell populations between cases of chronic and recurrent dermatophytosis and controls- treated and cured cases of dermatophytosisTimepoint: At the point of time of biopsy

Countries

India

Contacts

Public ContactDr Monisha Madhumita

Father Muller Medical College

mail.monisha.m@gmail.com8884440655

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026